Re: 'Use of androgen deprivation therapy in prostate cancer: indications and prevalence' by Connolly et al.
about
Re: 'Use of androgen deprivation therapy in prostate cancer: indications and prevalence' by Connolly et al.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Re: 'Use of androgen deprivati ...... prevalence' by Connolly et al.
@en
Re: 'Use of androgen deprivati ...... prevalence' by Connolly et al.
@nl
type
label
Re: 'Use of androgen deprivati ...... prevalence' by Connolly et al.
@en
Re: 'Use of androgen deprivati ...... prevalence' by Connolly et al.
@nl
prefLabel
Re: 'Use of androgen deprivati ...... prevalence' by Connolly et al.
@en
Re: 'Use of androgen deprivati ...... prevalence' by Connolly et al.
@nl
P2860
P356
P1476
Re: 'Use of androgen deprivati ...... prevalence' by Connolly et al.
@en
P2093
Bo-Eric Persson
P2860
P356
10.1038/AJA.2012.53
P577
2012-08-20T00:00:00Z